medRxivGenetic & Genomic MedicinePreprint
Variation at COMT, ADH1B-ADH1C and HTR2A loci is associated with genetic predisposition to substance use disorders in Ukrainians
V. V. BashynskaiD, Oksana Zahorodnia, Yuliia BorysovychiD, Yaroslav ZaplatnikoviD, Valeriia VasylievaiD, Ihor ArefieviD, Nariman DarvishoviD, Dariia Osychanska, Arthur Karapetov, O. Melnychuk, Olena Boiko, Zil'berblat Gm, Olena I. TurosiD, Inga ProkopenkoiD, Marika A. KaakineniD
Abstract
BackgroundSubstance use disorders (SUDs), including alcohol and drug dependence, and smoking, pose a public health threat with their high prevalence and comorbidity with other diseases, and contribution to mortality. SUDs are highly correlated, and their genetic background is shared to some degree. ObjectivesWe aimed to investigate the genetic associations of previously reported loci for a wide range of SUDs in an unstudied Ukrainian population. MethodsWe collected data from 595 individuals (339 women, 253 men), including 321 participants from two rehab centres. Based on clinical review and questionnaire data we defined drug dependence, alcohol dependence, alcohol abuse, binge drinking, smoking, opiate, amphetamine, cannabis, and hallucinogen use, along with several intermediary alcohol use and smoking variables considering the amount of use and the level of dependence. We genotyped COMT-rs4680, ADH1B-ADH1C-rs1789891, and HTR2A-rs6313, and applied logistic and ordered logistic regression assuming an additive inheritance model, controlling for the recruitment group, other substance uses, age, and sex, in the association analyses. ResultsWe replicate (P<0.05) the associations at COMT-rs4680 with smoking status (OR[95% CI]=1.56[1.01-2.41], P=0.047) and heaviness (1.37[1.04-1.80], P=0.026), and at ADH1B-ADH1C-rs1789891 and HTR2A-rs6313 with alcohol dependence (1.69[1.03-2.76], P=0.038 and 0.66[0.47-0.92, P=0.016], respectively). Furthermore, we provide evidence for an association at HTR2A-rs6313 with hallucinogen use (0.58[0.35-0.98], P=0.040). ConclusionIn this study on multiple SUDs we shed light on the genetic background of SUDs in Ukrainians and provide further evidence that variation at COMT is mainly associated with smoking, at ADH1B-ADH1C with alcohol-related variables, whereas HTR2A is a more general SUD-associated locus. HighlightsO_LIWe present the first genetic study of substance use disorders in Ukrainians C_LIO_LIWe replicate the associations at COMT-rs4680 with smoking status and heaviness, and ADH1B-ADH1C-rs1789891 and HTR2A-rs6313 with alcohol dependence C_LIO_LIWe provide evidence for an association at HTR2A-rs6313 with hallucinogen use C_LI
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Disentangling the shared genetics of ADHD, cannabis use disorder and cannabis use and prediction of cannabis use disorder in ADHD
Trine Tollerup Nielsen, Jinjie Duan, … Ditte Demontis·medRxiv·Feb 22, 2024
- Identification of novel risk loci with shared effects on alcoholism, heroin and methamphetamine dependence
Yan Sun, Suhua Chang, … Jie Shi·Molecular PsychiatryPeer-reviewed·Aug 28, 2019
- Substance use disorders exhibit unique and disorder specific genetic associations with externalizing and internalizing psychopathology
Holly E. Poore, Maia Choi, … Danielle M. Dick·medRxiv·Jan 22, 2026
- Genome-wide association meta-analysis of cocaine dependence: shared genetics with comorbid conditions
Judit Cabana‐Domínguez, Anu Shivalikanjli, … Bru Cormand·Progress in Neuro-Psychopharmacology and Biological PsychiatryPeer-reviewed·Jun 15, 2019
- Genome-wide association study of Alcohol Use Disorder Identification Test (AUDIT) scores in 20,328 research participants of European ancestry
Sandra Sanchez‐Roige, Pierre Fontanillas, … Abraham A. Palmer·Addiction BiologyPeer-reviewed·Oct 23, 2017
- Pleiotropic genetic architecture linking schizophrenia and substance use disorders
Selena Aranda, Dóra Koller, … Bru Cormand·medRxiv·Sep 4, 2026